XFLT: We May Not Have Found The Bottom Yet In This High-Yield CEF

XAI Octagon Floating Rate & Alternative Income Trust is rated Hold as it trades at a -15% discount to NAV after a -20% ...

US Fed rate cut, bond buy could draw FPIs to India, support rupee

The US Fed’s twin action of a rate cut and announcement that it will start buying US Treasury Bills could attract FPI ...

I’d Put My Whole 2025 TFSA Contribution Into This 6% Monthly Passive Income Payer

Explore whether investing your TFSA in one stock can maximize returns. Learn strategies for using the TFSA effectively.
The American Journal of Managed Care

Ianalumab Shows Disease-Modifying Potential for Early ITP in the Phase 3 VAYHIT2 Trial

A late-breaking presentation at the American Society of Hematology (ASH) 2025 meeting revealed promising phase 3 findings for ...
The Manila Times

Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumor…

IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...